Glazer Capital LLC’s Translational Development Acquisition Corp Warrants TDACW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-23,900
Closed -$7K 430
2025
Q3
$7K Sell
23,900
-26,100
-52% -$7.07K ﹤0.01% 295
2025
Q2
$12K Hold
50,000
﹤0.01% 227
2025
Q1
$7K Buy
+50,000
New +$8.79K ﹤0.01% 175

Other funds holding TDACW

Glazer Capital LLC's TDACW Position: Q4 2025 in Review

Glazer Capital LLC sold out of Translational Development Acquisition Corp Warrants (TDACW) in Q4 2025, closing a stake of 23,900 shares — an estimated $7K sold.

Glazer Capital LLC first reported a position in TDACW in Q1 2025 and held it in 3 quarters. The position peaked at $12K in Q2 2025. 33 funds tracked by Wall St. Rank hold TDACW as of Q4 2025.

  • Glazer Capital LLC reported no remaining Translational Development Acquisition Corp Warrants position as of Q4 2025 after selling out during the quarter.
  • Glazer Capital LLC sold 23,900 Translational Development Acquisition Corp Warrants shares in Q4 2025, an estimated $7K.
  • Glazer Capital LLC first reported a position in Translational Development Acquisition Corp Warrants in Q1 2025 and held it in 3 quarters.
  • Glazer Capital LLC's Translational Development Acquisition Corp Warrants position peaked at $12K in Q2 2025.
  • 33 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Warrants as of Q4 2025.

Based on Glazer Capital LLC's 13F filing for Q4 2025, filed 13 Feb 2026.